buformin has been researched along with Hyperlipoproteinemias in 2 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pados, G | 1 |
| Schulze, J | 1 |
| Julius, U | 1 |
| Leonhardt, W | 1 |
| Haller, H | 1 |
1 trial available for buformin and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Adverse effect of butylbiguanide therapy on alpha-lipoprotein cholesterol levels].
Topics: Biguanides; Buformin; Cholesterol; Clinical Trials as Topic; Humans; Hyperlipoproteinemias; Lipoprot | 1980 |
1 other study available for buformin and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Metabolism kinetic characterization of hypertriglyceridemias in drug therapy variations].
Topics: Adult; Blood Glucose; Buformin; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Delayed-Action P | 1987 |